Serum drug level-related sodium valproate-induced hair loss

Sodium valproate is a well-established treatment in epilepsy and mood disorders. Its utility is compromised by its adverse effects such as tremor, weight gain, hair loss, and liver dysfunction. Hair loss may occur when drug is used in higher dose. Drug-induced hair loss is diffused and non-scarring,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishnappa, Suresh K., Belhekar, Mahesh N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660934/
https://www.ncbi.nlm.nih.gov/pubmed/23716898
http://dx.doi.org/10.4103/0253-7613.108315
_version_ 1782270613767847936
author Ramakrishnappa, Suresh K.
Belhekar, Mahesh N.
author_facet Ramakrishnappa, Suresh K.
Belhekar, Mahesh N.
author_sort Ramakrishnappa, Suresh K.
collection PubMed
description Sodium valproate is a well-established treatment in epilepsy and mood disorders. Its utility is compromised by its adverse effects such as tremor, weight gain, hair loss, and liver dysfunction. Hair loss may occur when drug is used in higher dose. Drug-induced hair loss is diffused and non-scarring, which is reversible upon withdrawal. But there are no case reports showing relation between serum levels of valproate and occurrence of hair loss. So we took interest in reporting this case report.
format Online
Article
Text
id pubmed-3660934
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36609342013-05-28 Serum drug level-related sodium valproate-induced hair loss Ramakrishnappa, Suresh K. Belhekar, Mahesh N. Indian J Pharmacol Drug Watch Sodium valproate is a well-established treatment in epilepsy and mood disorders. Its utility is compromised by its adverse effects such as tremor, weight gain, hair loss, and liver dysfunction. Hair loss may occur when drug is used in higher dose. Drug-induced hair loss is diffused and non-scarring, which is reversible upon withdrawal. But there are no case reports showing relation between serum levels of valproate and occurrence of hair loss. So we took interest in reporting this case report. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3660934/ /pubmed/23716898 http://dx.doi.org/10.4103/0253-7613.108315 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Ramakrishnappa, Suresh K.
Belhekar, Mahesh N.
Serum drug level-related sodium valproate-induced hair loss
title Serum drug level-related sodium valproate-induced hair loss
title_full Serum drug level-related sodium valproate-induced hair loss
title_fullStr Serum drug level-related sodium valproate-induced hair loss
title_full_unstemmed Serum drug level-related sodium valproate-induced hair loss
title_short Serum drug level-related sodium valproate-induced hair loss
title_sort serum drug level-related sodium valproate-induced hair loss
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660934/
https://www.ncbi.nlm.nih.gov/pubmed/23716898
http://dx.doi.org/10.4103/0253-7613.108315
work_keys_str_mv AT ramakrishnappasureshk serumdruglevelrelatedsodiumvalproateinducedhairloss
AT belhekarmaheshn serumdruglevelrelatedsodiumvalproateinducedhairloss

Ejemplares similares